CRTC2 and non-small cell lung carcinoma: Recent studies have identified novel mutations and a high expression of CRTC2 in non-small cell lung cancer patients, leading to reinforced migration and invasion abilities of cancer cells (Shi et al., 2018; Rodón et al., 2019).